Clinical Trials Browser

poly ICLC × Tumor-Agnostic × 1 year × Clear all

NCT06614140 2026-04-22

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Phase 1/2 Completed

Neoplasms